438 related articles for article (PubMed ID: 16935891)
21. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.
Higurashi M; Ohya Y; Joh K; Muraguchi M; Nishimura M; Terawaki H; Yagui K; Hashimoto N; Saito Y; Yamada K
J Diabetes Complications; 2009; 23(3):178-84. PubMed ID: 18413205
[TBL] [Abstract][Full Text] [Related]
22. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K
Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
[TBL] [Abstract][Full Text] [Related]
24. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
[TBL] [Abstract][Full Text] [Related]
26. Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
Kajitani N; Shikata K; Nakamura A; Nakatou T; Hiramatsu M; Makino H
Diabetes Res Clin Pract; 2010 May; 88(2):171-6. PubMed ID: 20138680
[TBL] [Abstract][Full Text] [Related]
27. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
28. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
Murussi M; Campagnolo N; Beck MO; Gross JL; Silveiro SP
Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
[TBL] [Abstract][Full Text] [Related]
29. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.
Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH
Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173
[TBL] [Abstract][Full Text] [Related]
31. Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.
Bangstad HJ; Seljeflot I; Berg TJ; Hanssen KF
Scand J Clin Lab Invest; 2009; 69(1):138-44. PubMed ID: 18846477
[TBL] [Abstract][Full Text] [Related]
32. Retinopathy in type II diabetes mellitus associated with above-normal urinary excretion of RBP.
Holm J; Nielsen NV; Hemmingsen L
Kidney Int Suppl; 1994 Nov; 47():S105-8. PubMed ID: 7869657
[TBL] [Abstract][Full Text] [Related]
33. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
Navarro JF; Milena FJ; Mora C; León C; García J
Am J Nephrol; 2006; 26(6):562-70. PubMed ID: 17167242
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy.
Saraheimo M; Forsblom C; Pettersson-Fernholm K; Flyvbjerg A; Groop PH; Frystyk J;
Nephrol Dial Transplant; 2008 Mar; 23(3):914-8. PubMed ID: 18003664
[TBL] [Abstract][Full Text] [Related]
35. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
[TBL] [Abstract][Full Text] [Related]
36. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
Banu N; Hara H; Egusa G; Yamakido M
Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
[TBL] [Abstract][Full Text] [Related]
37. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
Tan Y; Yang Y; Zhang Z; Zhang X; Zhang Z; Liu Y
Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
[TBL] [Abstract][Full Text] [Related]
38. Tubular dysfunction in the early stage of diabetic nephropathy.
Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
[TBL] [Abstract][Full Text] [Related]
39. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria.
Bariş N; Erdoğan M; Sezer E; Saygili F; Mert Ozgönül A; Turgan N; Ersöz B
Acta Diabetol; 2009 Dec; 46(4):309-16. PubMed ID: 19183843
[TBL] [Abstract][Full Text] [Related]
40. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
